Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation
Publication
, Conference
Alexander, J; Andersson, U; Lopes, RD; Hijazi, Z; Hohnloser, SH; Ezekowitz, J; Halvorsen, S; Hanna, M; Granger, CB; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2015
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2015
Volume
36
Start / End Page
345 / 345
Location
London, ENGLAND
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Alexander, J., Andersson, U., Lopes, R. D., Hijazi, Z., Hohnloser, S. H., Ezekowitz, J., … Wallentin, L. (2015). Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. In EUROPEAN HEART JOURNAL (Vol. 36, pp. 345–345). London, ENGLAND: OXFORD UNIV PRESS.
Alexander, J., U. Andersson, R. D. Lopes, Z. Hijazi, S. H. Hohnloser, J. Ezekowitz, S. Halvorsen, M. Hanna, C. B. Granger, and L. Wallentin. “Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation.” In EUROPEAN HEART JOURNAL, 36:345–345. OXFORD UNIV PRESS, 2015.
Alexander J, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz J, et al. Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 345–345.
Alexander, J., et al. “Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation.” EUROPEAN HEART JOURNAL, vol. 36, OXFORD UNIV PRESS, 2015, pp. 345–345.
Alexander J, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz J, Halvorsen S, Hanna M, Granger CB, Wallentin L. Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 345–345.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2015
Volume
36
Start / End Page
345 / 345
Location
London, ENGLAND
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology